Abstract: [Problem] To provide a nucleic acid expected to be useful in treating mite allergy. [Solution] Provided is a nucleic acid including, in the following order: a base sequence that encodes a signal peptide; a base sequence that encodes an LAMP intra-organelle stabilizing domain; a base sequence that encodes an allergen domain including Derp1, Derp2, Derp23, and Derp7; a base sequence that encodes a transmembrane domain; and a base sequence that encodes an LAMP endosomal/lysosomal targeting domain, wherein the nucleic acid includes a base sequence that encodes a chimeric protein.
| # | Name | Date |
|---|---|---|
| 1 | 202047048818-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [09-11-2020(online)].pdf | 2020-11-09 |
| 2 | 202047048818-STATEMENT OF UNDERTAKING (FORM 3) [09-11-2020(online)].pdf | 2020-11-09 |
| 3 | 202047048818-SEQUENCE LISTING(PDF) [09-11-2020(online)].pdf | 2020-11-09 |
| 4 | 202047048818-SEQUENCE LISTING [09-11-2020(online)].txt | 2020-11-09 |
| 5 | 202047048818-PRIORITY DOCUMENTS [09-11-2020(online)].pdf | 2020-11-09 |
| 6 | 202047048818-FORM 1 [09-11-2020(online)].pdf | 2020-11-09 |
| 7 | 202047048818-DRAWINGS [09-11-2020(online)].pdf | 2020-11-09 |
| 8 | 202047048818-DECLARATION OF INVENTORSHIP (FORM 5) [09-11-2020(online)].pdf | 2020-11-09 |
| 9 | 202047048818-COMPLETE SPECIFICATION [09-11-2020(online)].pdf | 2020-11-09 |
| 10 | 202047048818-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [09-11-2020(online)].pdf | 2020-11-09 |
| 11 | 202047048818-Proof of Right [11-12-2020(online)].pdf | 2020-12-11 |
| 12 | 202047048818-FORM-26 [14-12-2020(online)].pdf | 2020-12-14 |
| 13 | 202047048818-Form1_After Filing_04-01-2021.pdf | 2021-01-04 |
| 14 | 202047048818-FORM 3 [23-04-2021(online)].pdf | 2021-04-23 |
| 15 | 202047048818-FORM 3 [10-05-2021(online)].pdf | 2021-05-10 |
| 16 | 202047048818.pdf | 2021-10-18 |
| 17 | 202047048818-FORM 3 [03-11-2021(online)].pdf | 2021-11-03 |
| 18 | 202047048818-Correspondence_Form-26_25-05-2022.pdf | 2022-05-25 |